Pneumocystis murina infection and cigarette smoke exposure interact to cause increased organism burden, development of airspace enlargement, and pulmonary inflammation in mice

Infection and Immunity

Volumn 76, Issue 8, 2008, Pages 3481-3490

  Christensen, Paul J ^a,b   Preston, Angela M ^a   Ling, Tony ^a   Du, Ming ^a   Fields, W Bradley ^a   Curtis, Jeffrey L ^a,b   Beck, James M ^a,b,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AIRSPACE ENLARGEMENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; C57BL 6 MOUSE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKE EXPOSURE; CLINICAL FEATURE; EMPHYSEMA; EXPOSURE; MOUSE; NONHUMAN; ORGANISM BURDEN; PATHOGENESIS; PNEUMOCYSTIS; PNEUMOCYSTIS MURINA; PNEUMOCYSTOSIS; PNEUMONIA; PRIORITY JOURNAL; TOTAL LUNG CAPACITY; ANIMAL; BACTERIAL COUNT; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; CYTOLOGY; FUNCTIONAL RESIDUAL CAPACITY; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; LUNG; LUNG LAVAGE; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MICROBIOLOGY; PATHOLOGY; SMOKE;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; COLONY COUNT, MICROBIAL; EMPHYSEMA; FUNCTIONAL RESIDUAL CAPACITY; LUNG; LYMPHOCYTE COUNT; LYMPHOCYTE SUBSETS; MICE; MICE, INBRED C57BL; PNEUMOCYSTIS; PNEUMONIA; SMOKE; TOTAL LUNG CAPACITY;

EID: 48849100793     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00165-08     Document Type: Article

References (55)

1. Ambrose, H. E., S. P. Keely, E. M. Aliouat, E. Dei-Cas, A. E. Wakefield, R. F. Miller, and J. R. Stringer. 2004. Expression and complexity of the PRT1 multigene family of Pneumocystis carinii. Microbiology 150:293-300.
2. An, C. L., F. Gigliotti, and A. G. Harmsen. 2003. Exposure of immunocompetent adult mice to Pneumocystis carinii f. sp. muris by cohousing: growth of P. carinii f. sp. muris and host immune response. Infect. Immun. 71:2065-2070.
3. Atzori, C., A. Mainini, F. Agostoni, E. Angeli, M. Bartlett, A. Bruno, M. Scaglia, and A. Cargnel. 1999. Detection of rat Pneumocystis carinii proteinases and elastase and antipneumocystis activity of proteinase inhibitors in vitro. Parasite 6:9-16.
4. Baybutt, R. C., and A. Molteni. 1999. Dietary beta-carotene protects lung and liver parenchyma of rats treated with monocrotaline. Toxicology 137: 69-80.
5. Beck, J. M., R. L. Newbury, B. E. Palmer, M. L. Warnock, P. K. Byrd, and H. B. Kaltreider. 1996. Role of CD8+ lymphocytes in host defense against Pneumocystis carinii in mice. J. Lab. Clin. Med. 128:477-487.
6. Beck, J. M., A. M. Preston, S. E. Wilcoxen, S. B. Morris, E. S. White, and R. Paine III. 2003. Pneumocystis pneumonia increases the susceptibility of mice to sublethal hyperoxia. Infect. Immun. 71:5970-5978.
7. Beck, J. M., M. J. Rosen, and H. H. Peavy. 2001. Pulmonary complications of HIV infection: report of the fourth NHLBI workshop. Am. J. Respir. Crit. Care Med. 164:2120-2126.
8. Borchers, M. T., S. C. Wesselkamper, N. L. Harris, H. Deshmukh, E. Beckman, M. Vitucci, J. W. Tichelaar, and G. D. Leikauf. 2007. CD8+ T cells contribute to macrophage accumulation and airspace enlargement following repeated irritant exposure. Exp. Mol. Pathol. 83:301-310.
9. Branden, E., H. Koyi, J. Gnarpe, H. Gnarpe, and G. Tornling. 2005. Chronic Chlamydia pneumoniae infection is a risk factor for the development of COPD. Respir. Med. 99:20-26.
10. Calderon, E., C. de la Horra, F. Medrano, A. Lopez-Suarez, M. Montes-Cano, N. Respaldiza, J. Elvira-Gonzalez, J. Martin-Juan, A. Bascunana, and J. Varela. 2004. Pneumocystis jiroveci isolates with dihydropteroate synthase mutations in patients with chronic bronchitis. Eur. J. Clin. Microbiol. Infect. Dis. 23:545-549.
11. Calderón, E. J., L. Rivero, N. Respaldiza, R. Morilla, M. A. Montes-Cano, V. Friaza, F. Muñoz-Lobato, J. M. Varela, F. J. Medrano, and C. de la Horra. 2007. Systemic inflammation in patients with chronic obstructive pulmonary disease who are colonized with Pneumocystis jiroveci. Clin. Infect. Dis. 45:17-19.
12. Chusid, M., and K. Heyrman. 1978. An outbreak of Pneumocystis carinii at a pediatric hospital. Pediatrics 62:1031-1035.
13. Conley, L. J., T. J. Bush, S. P. Buchbinder, K. A. Penley, F. N. Judson, and S. D. Holmberg. 1996. The association between cigarette smoking and selected HIV-related medical conditions. AIDS 10:1121-1126.
14. Crothers, K., A. A. Butt, C. L. Gibert, M. C. Rodriguez-Barradas, S. Crystal, and A. C. Justice. 2006. Increased COPD among HIV-positive compared to HIV-negative veterans. Chest 130:1326-1333.
15. Diaz, P. T., M. A. King, E. R. Pacht, M. D. Wewers, J. E. Gadek, H. N. Nagaraja, J. Drake, and T. L. Clanton. 2000. Increased susceptibility to pulmonary emphysema among HIV seropositive smokers. Ann. Intern. Med. 132:369-372.
16. Diaz, P. T., M. A. King, E. R. Pacht, M. D. Wewers, J. E. Gadek, D. Neal, H. N. Nagaraja, J. Drake, and T. L. Clanton. 1999. The pathophysiology of pulmonary diffusion impairment in human immunodeficiency virus infection. Am. J. Respir. Crit. Care Med. 160:272-277.
17. Dumoulin, A., E. Mazars, N. Seguy, D. Gargallo-Viola, S. Vargas, J. C. Cailliez, E. M. Aliouat, A. E. Wakefield, and E. Dei-Cas. 2000. Transmission of Pneumocystis carinii disease from immunocompetent contacts of infected hosts to susceptible hosts. Eur. J. Clin. Microbiol. Infect. Dis. 19:671-678.
18. Dunnill, M. S. 1962. Quantitative methods in the study of pulmonary pathology. Thorax 17:669-681.
19. Edwards, K., K. M. Braun, G. Evans, A. O. Sureka, and S. Fan. 1999. Mainstream and sidestream cigarette smoke condensates suppress macrophage responsiveness to interferon gamma. Hum. Exp. Toxicol. 18:233-240.
20. Harmsen, A. G., and M. Stankiewicz. 1990. Requirement for CD4+ cells in resistance to Pneumocystis carinii pneumonia in mice. J. Exp. Med. 172:937-945.
21. Hautamaki, R. D., D. K. Kobayashi, R. M. Senior, and S. D. Shapiro. 1997. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 277:2002-2004.
22. Helweg-Larsen, J., A. G. Tsolaki, R. F. Miller, B. Lundgren, and A. E. Wakefield. 1998. Clusters of Pneumocystis carinii pneumonia: analysis of person-to-person transmission by genotyping. Q. J. Med. 91:813-820.
23. Holt, P. G., and D. Keast. 1977. Environmentally induced changes in immunological function: acute and chronic effects of inhalation of tobacco smoke and other atmospheric contaminants in man and experimental animals. Bacteriol. Rev. 41:205-216.
24. Huang, L., A. Morris, A. H. Limper, and J. M. Beck. 2006. An official ATS workshop summary: recent advances and future directions in Pneumocystis pneumonia (PCP). Proc. Am. Thorac. Soc. 3:655-664.
25. Kurashima, K., T. Kanauchi, N. Takayanagi, N. Sato, D. Tokunaga, M. Ubukata, T. Yanagisawa, Y. Sugita, and M. Kanazawa. 2005. Serum IgG and IgA antibodies to Chlamydia pneumoniae and severity of emphysema. Respirology 10:572-578.
26. Lee, L. H., F. Gigliotti, T. W. Wright, P. J. Simpson-Haidaris, G. A. Weinberg, and C. G. Haidaris. 2000. Molecular characterization of KEX1, a kexin-like protease in mouse Pneumocystis carinii. Gene 242:141-150.
27. Lee, P., T. Gildea, and J. Stoller. 2002. Emphysema in nonsmokers: alpha 1-antitrypsin deficiency and other causes. Cleveland Clin. J. Med. 69:928-936.
28. Maeno, T., A. M. Houghton, P. A. Quintero, S. Grumelli, C. A. Owen, and S. D. Shapiro. 2007. CD8+ T cells are required for inflammation and destruction in cigarette smoke-induced emphysema in mice. J. Immunol. 178:8090-8096.
29. Majo, J., H. Ghezzo, and M. G. Cosio. 2001. Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema. Eur. Resp. J. 17:946-953.
30. Meng, Q. R., K. M. Gideon, S. J. Harbo, R. A. Renne, M. K. Lee, A. M. Brys, and R. R. Jones. 2006. Gene expression profiling in lung tissues from mice exposed to cigarette smoke, lipopolysaccharide, or smoke plus lipopolysaccharide by inhalation. Inhal. Toxicol. 18:555-568.
31. Meshi, B., T. Z. Vitalis, D. Ionescu, W. M. Elliott, C. Liu, X. D. Wang, S. Hayashi, and J. C. Hogg. 2002. Emphysematous lung destruction by cigarette smoke. The effects of latent adenoviral infection on the lung inflammatory response. Am. J. Respir. Cell Mol. Biol. 26:52-57.
32. Miguez-Burbano, M. J., D. Ashkin, A. Rodriguez, R. Duncan, A. Pitchenik, N. Quintero, M. Flores, and G. Shor-Posner. 2005. Increased risk of Pneumocystis carinii and community-acquired pneumonia with tobacco use in HIV disease. Int. J. Infect. Dis. 9:208-217.
33. Miguez-Burbano, M. J., X. Burbano, D. Ashkin, A. Pitchenik, R. Allan, L. Pineda, N. Rodriguez, and G. Shor-Posner. 2003. Impact of tobacco use on the development of opportunistic respiratory infections in HIV seropositive patients on antiretroviral therapy. Addict. Biol. 8:39-43.
34. Möller, L. V., W. Timens, W. van der Bij, K. Kooi, B. de Wever, J. Dankert, and L. van Alphen. 1998. Haemophilus influenzae in lung explants of patients with end-stage pulmonary disease. Am. J. Respir. Crit. Care Med. 157:950-956.
35. Morris, A., F. C. Sciurba, I. P. Lebedeva, A. Githaiga, W. M. Elliott, J. C. Hogg, L. Huang, and K. A. Norris. 2004. Association of chronic obstructive pulmonary disease severity and Pneumocystis colonization. Am. J. Respir. Crit. Care Med. 178:408-413.
36. Norris, K. A., A. Morris, S. Patil, and E. Fernandes. 2006. Pneumocystis colonization, airway inflammation, and pulmonary function decline in acquired immunodeficiency syndrome. Immunol. Res. 36:175-187.
37. Pavord, I. D., S. S. Birring, M. Berry, R. H. Green, C. E. Brightling, and A. J. Wardlaw. 2006. Multiple inflammatory hits and the pathogenesis of severe airway disease. Eur. Respir. J. 27:884-888.
38. Robbins, C. S., D. E. Dawe, S. I. Goncharova, M. A. Pouladi, A. G. Drannik, F. K. Swirski, G. Cox, and M. R. Stampfli. 2004. Cigarette smoke decreases pulmonary dendritic cells and impacts antiviral immune responsiveness. Am. J. Respir. Cell Mol. Biol. 30:202-211.
39. Roths, J. B., and C. L. Sidman. 1992. Both immunity and hyperresponsiveness to Pneumocystis carinii result from transfer of CD4+ but not CD8+ T cells into severe combined immunodeficiency mice. J. Clin. Investig. 90:673-678.
40. Rudmann, D. G., A. M. Preston, M. W. Moore, and J. M. Beck. 1998. Susceptibility to Pneumocystis carinii in mice depends on simultaneous depletion of interferon-gamma and type 1 and 2 tumor necrosis factor receptor genes. J. Immunol. 161:360-366.
41. Russian, D. A., and S. J. Levine. 2001. Pneumocystis carinii pneumonia in patients without HIV infection. Am. J. Med. Sci. 321:56-65.
42. Saah, A. J., D. R. Hoover, Y. Peng, J. P. Phair, B. Visscher, L. A. Kingsley, L. K. Schrager, et al. 1995. Predictors for failure of Pneumocystis carinii pneumonia prophylaxis. JAMA 273:1197-1202.
43. Saetta, M. 1999. Airway inflammation in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 160:S17-S20.
44. Saetta, M., S. Baraldo, L. Corbino, G. Turato, F. Braccioni, F. Rea, G. Cavallesco, G. Tropeano, C. E. Mapp, P. Maestrelli, A. Ciaccia, and L. M. Fabbri. 1999. CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 160:711-717.
45. Sethi, K. K. 1990. Application of immunoblotting to detect soluble Pneumocystis carinii antigen(s) in bronchoalveolar lavage of patients with Pneumocystis pneumonia and AIDS. J. Clin. Pathol. 43:584-586.
46. Shapiro, S. D. 2000. Animal models for chronic obstructive pulmonary disease: age of klotho and marlboro mice. Am. J. Respir. Cell Mol. Biol. 22:4-7.
47. Shellito, J., V. V. Suzara, W. Blumenfeld, J. M. Beck, H. J. Steger, and T. H. Ermak. 1990. A new model of Pneumocystis carinii infection in mice selectively depleted of helper T lymphocytes. J. Clin. Investig. 85:1686-1693.
48. Shellito, J. E., J. K. Kolls, R. Olariu, and J. M. Beck. 1996. Nitric oxide and host defense against Pneumocystis carinii infection in a mouse model. J. Infect. Dis. 173:432-439.
49. Shivji, M., S. Burger, C. A. Moncada, A. B. J. Clarkson, and S. Merali. 2005. Effect of nicotine on lung S-adenosylmethionine and development of Pneumocystis pneumonia. J. Biol. Chem. 280:15219-15228.
50. Singer, C., D. Armstrong, P. Rosen, and D. Schottenfeld. 1975. Pneumocystis carinii pneumonia: a cluster of eleven cases. Ann. Intern. Med. 82:772-777.
51. Sisson, T. H., J. M. Hansen, M. Shah, K. E. Hanson, M. Du, T. Ling, R. H. Simon, and P. J. Christensen. 2006. Expression of the reverse tetracycline-transactivator gene causes emphysema-like changes in mice. Am. J. Respir. Cell Mol. Biol. 34:552-560.
52. Wright, J. L., and A. Churg. 2007. Current concepts in mechanisms of emphysema. Toxicol. Pathol. 35:111-115.
53. Wright, T. W., F. Gigliotti, J. N. Finkelstein, J. T. McBride, C. L. An, and A. G. Harmsen. 1999. Immune-mediated inflammation directly impairs pulmonary function, contributing to the pathogenesis of Pneumocystis carinii pneumonia. J. Clin. Investig. 104:1307-1317.
54. Wright, T. W., R. H. Notter, Z. Wang, A. G. Harmsen, and F. Gigliotti. 2001. Pulmonary inflammation disrupts surfactant function during Pneumocystis carinii pneumonia. Infect. Immun. 69:758-764.
55. Zheng, M. Q., J. E. Shellito, L. Marrero, Q. Zhong, S. Julian, P. Ye, V. Wallace, P. Schwarzenberger, and J. K. Kolls. 2001. CD4+ T cell-independent vaccination against Pneumocystis carinii in mice. J. Clin. Investig. 108: 1469-1474.